Aziyo Biologics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Aziyo Biologics generated cash of -$21,434,000, which is less than the previous year. Cash used in financing activities reached the amount of $8,535,000 last year. Net change in cash is therefore -$13,439,000.
Cash Flow
| 2018 | -5.44M | -190K | 7.31M |
|---|---|---|---|
| 2019 | -7.22M | -577K | 7.97M |
| 2020 | -13.62M | -640K | 51.20M |
| 2021 | -15.44M | -369K | 6.71M |
| 2022 | -21.43M | -540K | 8.53M |
AZYO Cash Flow Statement (2018 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Cash at beginning of period | 30.42M | 39.53M | 2.59M | 2.41M | 739K |
Operating activities | |||||
Net income | -32.89M | -24.83M | -21.82M | -11.93M | -11.56M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 3.73M | 3.73M | 3.86M | 3.85M | 3.81M |
Stock-based compensation expense | 3.64M | 3.53M | 779K | 208K | 266K |
| Deferred income tax benefit | 3.64M | 3.53M | 779K | 208K | 266K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -834K | 1.17M | 64K | -30K | -1.61M |
Inventories | -498K | 563K | -2.92M | 269K | 1.09M |
Accounts payable | 4.90M | 1.19M | 261K | -627K | 352K |
Cash generated by operating activities | -21.43M | -15.44M | -13.62M | -7.22M | -5.44M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -540K | -369K | -640K | -577K | -190K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -540K | -369K | -640K | -577K | -190K |
Financing activities | |||||
Common Stock Issued | 10.40M | 13.96M | 43.02M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -4.52M | -300K | 0 | -5.45M |
Cash used in financing activities | 8.53M | 6.71M | 51.20M | 7.97M | 7.31M |
Net Change In Cash | -13.43M | -9.10M | 36.94M | 177K | 1.67M |
Cash at end of period | 16.98M | 30.42M | 39.53M | 2.59M | 2.41M |
| Data source | Data source | Data source |